NCT02194738 2026-03-18
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
National Cancer Institute (NCI)
Phase NA Active not recruiting
Clinical Trials
15 trialsNCT07436390 2026-03-02
MAK
Institute of Oncology Ljubljana
Phase NA Completed
NCT07422779 2026-02-20
MAK
Institute of Oncology Ljubljana
Phase NA Recruiting
NCT04603248 2026-02-12
A Study for Identification of Immune Determinants for Response to Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
Yonsei University
Phase NA Active not recruiting
NCT05533983 2025-12-03
NIVO-FMT
Asan Medical Center
Phase NA Recruiting
NCT07233668 2025-12-03
IVE in mRCC
Seoul National University Hospital
Phase NA Not yet recruiting
NCT06519682 2025-08-29
A Pilot Study Investigating Upfront Adaptive Immunotherapy Approach in Children, Adolescent and Young Adult (CAYA) Patients With Replication-Repair Deficient (RRD) High-Grade Gliomas (HGG)
The Hospital for Sick Children
Phase NA Recruiting
NCT07053202 2025-07-08
TACE With Immune Agents for Angiogenesis in Hepatocellular Carcinoma
The First Hospital of Hebei Medical University
Phase NA Completed
NCT05652673 2025-02-28
Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial
Erasmus Medical Center
Phase NA Recruiting
NCT04256213 2024-12-12
COLIBRI
ARCAGY/ GINECO GROUP
Phase NA Completed
NCT02833233 2024-10-23
A Study of Pre-Operative Treatment With Cryoablation and Immune Therapy in Early Stage Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT05745233 2023-08-24
Intraperitoneal Immune Checkpoint Inhibitor for Malignant Ascites
China Medical University Hospital
Phase NA Enrolling by invitation
NCT04801966 2023-05-10
TAILOR
Peter MacCallum Cancer Centre, Australia
Phase NA Terminated
NCT05233358 2022-02-10
HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure
The Central Hospital of Lishui City
Phase NA Unknown
NCT05001360 2021-10-27
Study of FMT Combined With Nivolumab in Gastric Cancer
Fujian Cancer Hospital
Phase NA Withdrawn